Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
56,538,511
-
Shares change
-
+13,834,629
-
Total reported value, excl. options
-
$1,003,523,628
-
Value change
-
+$261,143,310
-
Put/Call ratio
-
0.68%
-
Number of buys
-
91
-
Number of sells
-
-42
-
Price
-
$17.75
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2022
155 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,538,511 shares
of 202,731,676 outstanding shares and own 28% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (9,710,000 shares), VANGUARD GROUP INC (5,069,119 shares), BlackRock Inc. (3,929,424 shares), EVENTIDE ASSET MANAGEMENT, LLC (3,693,720 shares), Logos Global Management LP (3,150,000 shares), STATE STREET CORP (3,112,943 shares), BVF INC/IL (2,561,000 shares), FMR LLC (2,488,133 shares), Alpine Global Management, LLC (1,500,000 shares), and DIMENSIONAL FUND ADVISORS LP (1,297,608 shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.